{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:01:26Z","timestamp":1761512486402},"reference-count":49,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.1210\/jc.2007-1402","type":"journal-article","created":{"date-parts":[[2008,1,4]],"date-time":"2008-01-04T19:58:25Z","timestamp":1199476705000},"page":"2-7","source":"Crossref","is-referenced-by-count":43,"title":["Approach to the Prostate Cancer Patient with Bone Disease"],"prefix":"10.1210","volume":"93","author":[{"given":"Susan L.","family":"Greenspan","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine, Clinical and Translational Research Center, Osteoporosis Prevention and Treatment Center, Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114134448700_R1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00223-004-4002-4","article-title":"Osteoporosis in men\u2014consensus is premature.","volume":"75","author":"Seeman","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041114134448700_R2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025.","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114134448700_R3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-006-0160-8","article-title":"Bone fragility in men\u2014where are we?","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114134448700_R4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1359\/JBMR.041133","article-title":"Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures.","volume":"20","author":"Jiang","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114134448700_R5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","article-title":"Prevalence of low femoral bone density in older U.S. adults from NHANES III.","volume":"12","author":"Looker","year":"1997","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114134448700_R6","first-page":"3431","article-title":"Osteoporosis in men.","volume":"84","author":"Bilezikian","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.0.1390257","article-title":"Delayed puberty and peak bone mass.","volume":"139","author":"Bonjour","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114134448700_R8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0889-8529(02)00058-0","article-title":"Establishment of peak bone mass.","volume":"32","author":"Mora","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key\n\t\t\t\t2019041114134448700_R9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00297293","article-title":"Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data.","volume":"50","author":"Beck","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041114134448700_R10","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","article-title":"Pathogenesis of bone fragility in women and men.","volume":"359","author":"Seeman","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114134448700_R11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.blo.0000136842.75487.e2","article-title":"Osteoporosis: a disease in men.","volume":"425","author":"Stock","year":"2004","journal-title":"Clin Orthop"},{"key":"key\n\t\t\t\t2019041114134448700_R12","first-page":"745","article-title":"Osteoporosis in men","author":"Orwoll","year":"1996","journal-title":"In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press;"},{"key":"key\n\t\t\t\t2019041114134448700_R13","first-page":"290","article-title":"Osteoporosis in men","author":"Orwoll","year":"2006","journal-title":"In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington, DC: American Society for Bone and Mineral Research;"},{"key":"key\n\t\t\t\t2019041114134448700_R14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis.","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114134448700_R15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report.","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114134448700_R16","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"Official positions of the International Society for Clinical Densitometry.","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R17","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women.","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00198-007-0381-5","article-title":"An evaluation of densitometric vertebral fracture assessment in men.","volume":"18","author":"Vallarta-Ast","year":"2007","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114134448700_R19","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2006-1178","article-title":"Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry.","volume":"91","author":"Lewiecki","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1385\/JCD:4:4:373","article-title":"Instant vertebral assessment: a noninvasive DXA technique to avoid misclassification and clinical mismanagement of osteoporosis.","volume":"4","author":"Greenspan","year":"2001","journal-title":"J Clin Densitom"},{"key":"key\n\t\t\t\t2019041114134448700_R21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM199410133311507","article-title":"Management of cancer of the prostate.","volume":"331","author":"Catalona","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114134448700_R22","first-page":"293","article-title":"Studies in prostate cancer: 1. The effects of castration, of estrogen, and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate.","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114134448700_R23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ucl.2004.01.001","article-title":"Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.","volume":"31","author":"Higano","year":"2004","journal-title":"Urol Clin North Am"},{"key":"key\n\t\t\t\t2019041114134448700_R24","first-page":"235","article-title":"Immediate vs. deferred treatment for advanced prostatic cancer: initial results of the MRC Trial.","volume-title":"Brit J Urol","author":"MRC Prostate Cancer Working Party Investigator\u2019s Group","year":"1997"},{"key":"key\n\t\t\t\t2019041114134448700_R25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114134448700_R26","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma.","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114134448700_R27","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R28","first-page":"2787","article-title":"Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists.","volume":"86","author":"Stoch","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO;2-3","article-title":"Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate cancer.","volume":"79","author":"Townsend","year":"1997","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114134448700_R30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer.","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114134448700_R31","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041114134448700_R32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.","volume":"345","author":"Smith","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114134448700_R33","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","article-title":"Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041114134448700_R34","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2006.07.3361","article-title":"Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.","volume":"25","author":"Michaelson","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041114134448700_R35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-146-6-200703200-00006","article-title":"Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer. A randomized trial.","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041114134448700_R36","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1210\/jc.2003-032058","article-title":"Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114134448700_R37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14712598.6.10.1041","article-title":"RANK ligand inhibition with denosumab for the management of osteoporosis.","volume":"6","author":"Lewiecki","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t2019041114134448700_R38","year":"2003"},{"key":"key\n\t\t\t\t2019041114134448700_R39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114134448700_R40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status.","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114134448700_R41","first-page":"340","article-title":"Management of osteoporosis in postmenopausal women: 2006 position statement of the North American Menopause Society.","volume-title":"Menopause","author":"North American Menopause Society","year":"2006"},{"key":"key\n\t\t\t\t2019041114134448700_R42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114134448700_R43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.juro.2006.08.089","article-title":"Bone health in men receiving androgen deprivation therapy for prostate cancer.","volume":"177","author":"Eastham","year":"2007","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019041114134448700_R44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eururo.2003.10.003","article-title":"Role of bisphosphonates in prostate cancer.","volume":"45","author":"Saad","year":"2004","journal-title":"Eur Urol"},{"issue":"3 Suppl","key":"key\n\t\t\t\t2019041114134448700_R45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/cncr.11149","article-title":"Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma","volume":"97","author":"Smith","year":"2003","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114134448700_R46","first-page":"442","article-title":"Calcium and fructose intake in relation to risk of prostate cancer.","volume":"58","author":"Giovannucci","year":"1998","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041114134448700_R47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1008823601897","article-title":"Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden).","volume":"9","author":"Chan","year":"1998","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t2019041114134448700_R48","first-page":"167","article-title":"Dietary influences of 1,25 (OH)2 vitamin D in relation to prostate cancer: a hypothesis.","volume":"9","author":"Giovannucci","year":"1998","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t2019041114134448700_R49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989.","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/1\/2\/9051397\/jcem0002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T14:51:54Z","timestamp":1557154314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/1\/2\/2597911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1402","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}